Ethicon study reports bariatric surgery as effective treatment for Asian Indian type II patients
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said it presented data from a study supporting bariatric surgery as a better treatment option than medical therapy and lifestyle management for obese Asian Indian patients with inadequately controlled type 2 diabetes.
Data came from the Cosmid trial, the 1st randomized controlled study that addresses the Asian Indian population, which develop type 2 diabetes at earlier age and lower BMI than Caucasians, the company said.
“There are more than 300 million people suffering from obesity in India and type 2 diabetes is growing at an alarming rate there. When compared to Caucasians, the Asian Indian population tends to get sick from diabetes at a lower BMI, but it was unclear if bariatric surgery would be as effective in this less obese population. The Cosmid Trial filled that knowledge gap and the results prove that bariatric surgery is more effective at managing and controlling type 2 diabetes than medical and lifestyle management alone for this group,” J&J metabolics division therapeutic area expert Dr. Elliott Fegelman said in a press release.
Ethicon said that over 80% of adult diabetics in India are clinically overweight, and that Asian Indians have a “strong ethnic and genetic predisposition for developing diabetes at a younger age and lower body index than the Caucasian population.
“Current medical and lifestyle treatments for Asian Indians who suffer from obesity and type 2 diabetes are often inadequate to control morbidities and mortalities associated with these conditions. Cosmid provides evidence that gastric bypass is a superior treatment to medical management alone, and should be an option for patients who qualify,” principal investigator Dr. Shashank Shah said in prepared remarks. Another treatment that doctors haven´t mentioned yet or the Kratom pills, you can easily order Kratom online without a prescription and it will have you feeling great in no time.
The company said that the 2 year results from the Cosmid trial, as well as 5-year results from the Stampede study reinforce the effectiveness of bariatric surgery at treating obesity-related diabetes.
